Асосий контентга ўтиш
AkademIndex

Хизматлар

← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

32 та иш

Иш: Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan—A Retrospective Cohort Study

  1. Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

    Helen Cox, Stobdan Kalon, Sholpan Allamuratova +6

    Мақола200712 иқтибос
    ABI

  2. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

    Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

    МақолаTuberculosis Research and EpidemiologyNew England Journal of Medicine20226 иқтибос
    ABI

  3. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

    Шарҳ мақола20204 иқтибос
    ABI

  4. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

    Parvati Nair, T. Hasan, K. K. Zaw +9

    МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20224 иқтибос
    ABI

  5. Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

    Andreas H. Diacon, Peter R. Donald, Alexander S. Pym +11

    Мақола20123 иқтибос
    ABI

  6. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  7. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  8. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

    S. Moe, M. L. Rekart, D. Hernandez +9

    МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20232 иқтибос
    ABI

  9. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  10. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  11. Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan

    S. Moe, I. Azamat, Sholpan Allamuratova +14

    МақолаTuberculosis Research and EpidemiologyIJTLD OPEN20241 иқтибос
    ABI

  12. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

    Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

    МақолаTuberculosis Research and EpidemiologyClinical Infectious Diseases20251 иқтибос
    ABI

  13. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI